Skip to main content

National Jewish Health

National Jewish Health
Denver, Colorado
SOURCE: SPIROMICS Study of Early COPD Progression is looking for current and former cigarette smokers between 30 and 55 years old to participate in a research study on early signs of lung disease. Most studies of lung disease and Chronic Obstructive Pulmonary Disease (COPD) involve older people. This 5-year study in 12 cities across the U.S. will help us better understand COPD in younger people. You do not need a COPD diagnosis to join.

Study Site Location

National Jewish Health
Clinical Translational Research Center (CTRC)
1400 Jackson Street
Denver, CO 80206

(303) 398-1943 jonesa@njhealth.org
Russell Bowler
Russell Bowler, MD, PhD
Principal Investigator
COPD is a leading cause of death among smokers, yet we know little about the origins of early COPD. Your participation in the source study will help us understand which smokers are at risk of progression to COPD and the factors that increase this risk.
Alex M. Jones
Alex M. Jones, MSW
Clinical Research Coordinator
(303)398-1943
true

Are you eligible to join?

Current and former cigarette smokers are eligible. No COPD diagnosis is necessary. Answer the screening questions by entering your age and the numbers of years smoked. If you are eligible, you’ll be asked for your contact information. By submitting your contact information you’re agreeing to be contacted about this study.

Individuals between the ages of 30 and 55 who are current or former cigarette smokers may qualify for this study on early COPD.